financetom
Business
financetom
/
Business
/
Why Bed Bath & Beyond Stock Is Rising Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Bed Bath & Beyond Stock Is Rising Today
Nov 25, 2025 9:21 AM

Bed Bath & Beyond, Inc. ( BBBY ) shares traded higher on Tuesday after the retailer unveiled new deal plans.

Bed Bath & Beyond ( BBBY ) agreed to acquire The Brand House Collective, Inc. ( TBHC ) in an all-stock transaction valuing the target at about $26.8 million, using Nov. 21 closing prices.

The agreement gives Brand House investors 0.1993 Bed Bath & Beyond ( BBBY ) shares for each Brand House share.

Also Read: Jim Cramer: This Tech Stock Is ‘Losing Too Much Money', Recommends Buying Mettler-Toledo

That exchange ratio reflects both companies' 30-day volume-weighted average prices through Nov. 20.

Bed Bath & Beyond ( BBBY ) already owns roughly 40% of Brand House's outstanding stock and has committed to supporting the merger.

The company also advanced $10 million under an existing delayed draw term loan to speed store conversions and omnichannel inventory builds.

Strategic Push Toward ‘Everything Home'

Executive Chairman Marcus Lemonis framed the acquisition as a key step toward a broader home-focused ecosystem.

"This acquisition is a big step in building a profitable, growth oriented Everything Home company. The power of this deal comes from a more efficient and productive engagement with the consumer, while extracting over $20 million in duplicate costs," said Lemonis.

After the transaction closes, Brand House Chief Executive Officer Amy Sullivan is expected to lead a new Beyond Retail Group division.

She will oversee merchandising, stores, e-commerce and customer experience across brands, including Bed Bath & Beyond ( BBBY ), buybuy BABY, Overstock and Kirkland's Home.

Lemonis said Sullivan has driven the partnership over the past year and fits his standards for customer focus and operational discipline.

Customer Growth And Profitability Goals

"Our focus is clear: we will put the customer at the center of every decision, differentiate our brands with intention, and accelerate customer growth and lifetime value in ways that drive meaningful revenue and sustainable profitability," said Sullivan.

Management expects at least $20 million in annual cost eliminations as overlapping roles and systems disappear.

The combined company plans to reinvest those savings into high-conversion formats, digital upgrades and data-driven customer acquisition tools.

More than 40 underperforming or noncore locations are slated to close in early 2026 to support margin improvement and inventory efficiency.

The boards of both companies approved the merger unanimously. The deal still requires Brand House shareholder approval, including a majority of disinterested holders, and lender consent from Bank of America.

The companies said they aim to finalize the transaction in the first quarter of 2026.

BBBY Price Action: Bed Bath & Beyond ( BBBY ) shares were up 2.66% at $5.78 at the time of publication on Tuesday. The stock is near its 52-week low of $5.47, according to Benzinga Pro data. TBHC shares were down 9.02% at the time of publication.

Read Next:

One-Fourth Of America's Unemployed Are Now College Grads— Chamath Palihapitiya Warns Student Loans Are Fueling The Crisis

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said in a statement that the...
Automotive Properties REIT Declares January 2025 Distribution
Automotive Properties REIT Declares January 2025 Distribution
Jan 15, 2025
03:49 PM EST, 01/15/2025 (MT Newswires) -- Automotive Properties REIT (APR-UN.TO) Wednesday declared a distribution of $0.067 per REIT unit for the month of January, representing $0.804 per REIT unit on an annualized basis. This is consistent with December's cash distribution. Payment will be made on Feb. 18 to unitholders of record on Jan. 31. Price: 10.66, Change: +0.08, Percent...
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
Jan 15 (Reuters) - Gilead Sciences ( GILD ) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said...
Senators demand US trade chief Tai halt late talks on investor protections
Senators demand US trade chief Tai halt late talks on investor protections
Jan 15, 2025
WASHINGTON (Reuters) - A bipartisan group of U.S. senators on Wednesday called on U.S. Trade Representative Katherine Tai to stop secret negotiations with Mexico, Canada and Colombia that would weaken investor protections in some U.S. free trade deals during the Biden administration's final days. The letter, led by Senate Finance Committee Chairman Mike Crapo, a Republican, and the panel's top...
Copyright 2023-2025 - www.financetom.com All Rights Reserved